A new study has suggested that treatment with high-potency statins offers a significantly improved chance of survival following a heart attack, slashing the risk of early death.
It is already known that statins, drugs used to lower cholesterol levels, cut deaths from heart disease and stroke as well as protecting against serious infections and respiratory illnesses such as pneumonia, the Daily Express reported.
However, researchers have now found that taking a more potent form of the wonder drug can significantly improve survival rates for heart attack patients.
According to professor Chim Lang, who led the research, the pill should be handed out to patients routinely after a heart attack.
The study examined data from thousands of UK patients and showed those treated with high-potency statins had a 28 percent lower risk of dying within three years of their first heart attack.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
